دورية أكاديمية
[Heart transplantation in Norway].
| العنوان: | [Heart transplantation in Norway]. |
|---|---|
| عنوان ترانسليتريتد: | Hjertetransplantasjon i Norge. |
| المؤلفون: | Simonsen S; Hjertemedisinsk avdeling, Rikshospitalet, Oslo., Andreassen AK, Gullestad L, Lindberg H, Seem E, Geiran OR |
| المصدر: | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 1999 Sep 30; Vol. 119 (23), pp. 3447-50. |
| نوع المنشور: | Journal Article |
| اللغة: | Norwegian |
| بيانات الدورية: | Publisher: Norske Laegeforening Country of Publication: Norway NLM ID: 0413423 Publication Model: Print Cited Medium: Print ISSN: 0029-2001 (Print) Linking ISSN: 00292001 NLM ISO Abbreviation: Tidsskr Nor Laegeforen Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oslo : Norske Laegeforening Original Publication: Chistiania : Alb. Cammermeyer, 1880- |
| مواضيع طبية MeSH: | Heart Transplantation*/mortality , Heart Transplantation*/statistics & numerical data, Adolescent ; Adult ; Child ; Child, Preschool ; Contraindications ; Female ; Follow-Up Studies ; Graft Rejection ; Humans ; Immunosuppressive Agents/administration & dosage ; Male ; Middle Aged ; Norway ; Patient Selection |
| مستخلص: | The first heart transplantation in the Nordic countries was performed at Rikshospitalet, Oslo in 1983. In this paper, we present our experience with this treatment up to 1999. 317 heart transplantations have been performed, an average of 23 transplantations per year. 82% of the recipients were males; 50% had heart failure due to coronary heart disease. Mean age of the recipients was 47 years (range 1-64). Our indications and contraindications are similar to most other transplantation centres. Triple immunosuppression with ciclosporin, prednisolone and azathioprine have been used as standard treatment. The survival rate after one and ten years are 85% and 53% respectively, with a significantly higher survival rate among recipients younger than 50 at transplantation, especially if the graft was from a donor younger than 35 years. The most common early postoperative complications were acute cellular rejections and infections. Transplant accelerated coronary heart disease and cancer were the main causes of late death. We believe that close co-operation between Riskshospitalet and local centres will provide the best treatment for patients needing a heart transplant. |
| المشرفين على المادة: | 0 (Immunosuppressive Agents) |
| تواريخ الأحداث: | Date Created: 19991130 Date Completed: 19991119 Latest Revision: 20171116 |
| رمز التحديث: | 20240627 |
| PMID: | 10553344 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0029-2001 |
|---|